时间:2022-05-30浏览次数:1226
SR-CPPS01 | TAT | GRKKRRQRRRPQ | Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Pro-Gln | |
SR-CPPS02 | 穿膜肽SynB1 | SynB1 | RGGRLSYSRRRFSTSTGR | Arg-Gly-Gly-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-Ser-Thr-Ser-Thr-Gly-Arg |
SR-CPPS03 | 穿膜肽CPPP-2 | CPPP-2 | KLPVM | Lys-Leu-Pro-Val-Met |
SR-CPPS04 | 穿膜肽PTD-5 | PTD-5 | RRQRRTSKLMKR | Arg-Arg-Gln-Arg-Arg-Thr-Ser-Lys-Leu-Met-Lys-Arg |
SR-CPPS05 | 穿膜肽HIV-Tat | HIV-Tat | YGRKKRRQRR | Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg |
SR-CPPS06 | 穿膜肽TAT(47-57) | TAT(47-57) | YGRKKRRQRRR | Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg |
SR-CPPS07 | 眼部转运肽 | POD | GGGARKKAAKAARKKAAKAARKKAAKAARKKAAKA | Gly-Gly-Gly-Ala-Arg-Lys-Lys-Ala-Ala-Lys-Ala-Ala-Arg-Lys-Lys-Ala-Ala-Lys-Ala-Ala-Arg-Lys-Lys-Ala-Ala-Lys-Ala-Ala-Arg-Lys-Lys-Ala-Ala-Lys-Ala |
SR-CPPS08 | 穿膜肽CADY | CADY | GLWRALWRLLRSLWRLLWRA-Cya | Gly-Leu-Trp-Arg-Ala-Leu-Trp-Arg-Leu-Leu-Arg-Ser-Leu-Trp-Arg-Leu-Leu-Trp-Arg-Ala-Cya |
SR-CPPS09 | 九聚精氨酸 | R9 | RRRRRRRRR | Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg |
SR-CPPS10 | 八聚精氨酸 | R8 | RRRRRRRR | Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg |
SR-CPPS11 | 穿膜肽MAP | MAP | KLALKLALKALKAALKLA | Lys-Leu-Ala-Leu-Lys-Leu-Ala-Leu-Lys-Ala-Leu-Lys-Ala-Ala-Leu-Lys-Leu-Ala |
SR-CPPS12 | 穿膜肽YTA4 | YTA4 | IAWVKAFIRKLRKGPLG-NH2 | Ile-Ala-Trp-Val-Lys-Ala-Phe-Ile-Arg-Lys-Leu-Arg-Lys-Gly-Pro-Leu-Gly-NH2 |
SR-CPPS13 | 穿膜肽YTA2,4 | YTA2,4 | YTAIAWVKAFIRKLRK-NH2 | Tyr-Thr-Ala-Ile-Ala-Trp-Val-Lys-Ala-Phe-Ile-Arg-Lys-Leu-Arg-Lys-NH2 |
SR-CPPS14 | 穿膜肽M918 | M918 | MVTVLFRRLRIRRACGPPRVRV-NH2 | Met-Val-Thr-Val-Leu-Phe-Arg-Arg-Leu-Arg-Ile-Arg-Arg-Ala-Cys-Gly-Pro-Pro-Arg-Val-Arg-Val-NH2 |
SR-CPPS15 | 穿膜肽TP10 | TP10 | GWTLNS | Gly-Trp-Thr-Leu-Asn-Ser |
SR-CPPS16 | 穿膜肽Pep-1 | Pep-1 | KETWWETWWTEWSQPKKKRKV-Cya | Lys-Glu-Thr-Trp-Trp-Glu-Thr-Trp-Trp-Thr-Glu-Trp-Ser-Gln-Pro-Lys-Lys-Lys-Arg-Lys-Val-Cya |
SR-CPPS17 | 穿膜肽MPG | MPG | GALFLGFLGAAGSTMGA-Cya | Gly-Ala-Leu-Phe-Leu-Gly-Phe-Leu-Gly-Ala-Ala-Gly-Ser-Thr-Met-Gly-Ala-Cya |
SR-CPPS18 | 穿膜肽VP22 | VP22 | NAKTRRHERRRKLAIER | Asn-Ala-Lys-Thr-Arg-Arg-His-Glu-Arg-Arg-Arg-Lys-Leu-Ala-Ile-Glu-Arg |
SR-CPPS19 | 穿膜肽pVEC | pVEC | LLIILRRRIRKQAHAHSK-NH2 | Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2 |
SR-CPPS20 | 穿膜肽TAT(48-60) | TAT(48-60) | GRKKRRQRRRPPQ | Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Pro-Pro-Gln |
电话:400-108-1628
销售邮箱:sales@scierbio.com
销售电话/微信:17682162835,13865214774,15212772361
技术支持/微信:17682162835
销售 QQ:475590620
上一篇:穿膜肽的结构特点与分类